MedPath

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Phase 3
Completed
Conditions
Advanced Stage Parkinson's Disease
Interventions
Registration Number
NCT00407095
Lead Sponsor
Solvay Pharmaceuticals
Brief Summary

This study is a multicenter, 9 months, open label extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.002 study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
140
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Pardoprunox-
Primary Outcome Measures
NameTimeMethod
Safety: laboratory data, adverse events, vital signs, ECG36 weeks
Secondary Outcome Measures
NameTimeMethod
On' and 'off' time recording, UPDRS parts 1-4, CGI-improvement, PDQ-39 total score: all change from baseline36 weeks

Trial Locations

Locations (87)

S308.3.007 Site # 221

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

S308.3.007 Site # 120

πŸ‡§πŸ‡¬

Sofia, Bulgaria

S308.3.007 Site # 141

πŸ‡¨πŸ‡±

Santiago de Chile, Chile

S308.3.007 Site # 132

πŸ‡¨πŸ‡¦

Markham, Canada

S308.3.007 Site # 118

πŸ‡§πŸ‡·

Porto Alegre, Brazil

S308.3.007 Site # 106

πŸ‡¦πŸ‡·

Buenos Aires, Argentina

S308.3.007 Site # 134

πŸ‡¨πŸ‡¦

Ottava, Canada

S308.3.007 Site # 114

πŸ‡§πŸ‡·

Alto da GlΓ³ria, Brazil

S308.3.007 Site # 215

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

S308.3.007 Site # 111

πŸ‡§πŸ‡·

Porto Alegre, Brazil

S308.3.007 Site # 104

πŸ‡¦πŸ‡·

Mar del Plata, Argentina

S308.3.007 Site # 109

πŸ‡¦πŸ‡·

Buenos Aires, Argentina

S308.3.007 Site # 210

πŸ‡ΊπŸ‡Έ

Tledo, Ohio, United States

S308.3.007 Site # 223

πŸ‡¦πŸ‡±

Birmingham, Albania

S308.3.007 Site # 123

πŸ‡§πŸ‡¬

Plovdiv, Bulgaria

S308.3.007 Site # 137

πŸ‡¨πŸ‡¦

Greenfield Park, Canada

S308.3.007 Site # 125

πŸ‡§πŸ‡·

Sao Paulo, Brazil

S308.3.007 Site # 217

πŸ‡ΊπŸ‡Έ

St. Louis, Missouri, United States

S308.3.007 Site # 124

πŸ‡§πŸ‡¬

Sofia, Bulgaria

S308.3.007 Site # 115

πŸ‡§πŸ‡·

SΓ’o Paulo, Brazil

S308.3.007 Site # 136

πŸ‡¨πŸ‡¦

Calgary, Canada

S308.3.007 Site # 122

πŸ‡§πŸ‡¬

Sofia, Bulgaria

S308.3.007 Site # 117

πŸ‡§πŸ‡·

RibeirΓ£o Preto, Brazil

S308.3.007 Site # 202

πŸ‡ΊπŸ‡¦

Kyiv, Ukraine

S308.3.007 Site # 195

πŸ‡·πŸ‡Ί

Saint-Petersburg, Russian Federation

S308.3.007 Site # 206

πŸ‡ΊπŸ‡¦

Kharkiv, Ukraine

S308.3.007 Site # 203

πŸ‡ΊπŸ‡¦

Poltava, Ukraine

S308.3.007 Site # 207

πŸ‡ΊπŸ‡¦

Zaporozhya, Ukraine

S308.3.007 Site # 205

πŸ‡ΊπŸ‡¦

Lviv, Ukraine

S308.3.007 Site # 216

πŸ‡ΊπŸ‡Έ

Kansas City, Kansas, United States

S308.3.007 Site # 150

πŸ‡¨πŸ‡΄

Medellin, Colombia

S308.3.007 Site # 160

πŸ‡±πŸ‡»

Riga, Latvia

S308.3.007 Site # 182

πŸ‡΅πŸ‡ͺ

Lima, Peru

S308.3.007 Site # 143

πŸ‡¨πŸ‡±

Santiago de Chile, Chile

S308.3.007 Site # 151

πŸ‡¨πŸ‡΄

Bogota, Colombia

S308.3.007 Site # 152

πŸ‡¨πŸ‡΄

Bogota, Colombia

S308.3.007 Site # 196

πŸ‡·πŸ‡Ί

Yaroslavl, Russian Federation

S308.3.007 Site # 204

πŸ‡ΊπŸ‡¦

Dnepropetrovsk, Ukraine

S308.3.007 Site # 201

πŸ‡ΊπŸ‡¦

Kyiv, Ukraine

S308.3.007 Site # 197

πŸ‡·πŸ‡Ί

Moscow, Russian Federation

S308.3.007 Site # 142

πŸ‡¨πŸ‡±

Valdivia, Chile

S308.3.007 Site # 172

πŸ‡±πŸ‡Ή

Kaunas, Lithuania

S308.3.007 Site # 190

πŸ‡·πŸ‡Ί

Moscow, Russian Federation

S308.3.007 Site # 194

πŸ‡·πŸ‡Ί

Moscow, Russian Federation

S308.3.007 Site # 208

πŸ‡ΊπŸ‡¦

Simferopol, Ukraine

S308.3.007 Site # 200

πŸ‡ΊπŸ‡¦

Vinnytsya, Ukraine

S308.3.007 Site # 119

πŸ‡§πŸ‡·

Salvador, Brazil

S308.3.007 Site # 110

πŸ‡§πŸ‡·

SΓ£o Paulo, Brazil

S308.3.007 Site # 153

πŸ‡¨πŸ‡΄

Bogota, Colombia

S308.3.007 Site # 211

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

S308.3.007 Site # 218

πŸ‡ΊπŸ‡Έ

Gainsville, Florida, United States

S308.3.007 Site # 222

πŸ‡ΊπŸ‡Έ

Durham, North Carolina, United States

S308.3.007 Site # 213

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

S308.3.007 Site # 220

πŸ‡ΊπŸ‡Έ

LaJolla, California, United States

S308.3.007 Site # 214

πŸ‡ΊπŸ‡Έ

Fort Lauderdale, Florida, United States

S308.3.007 Site # 224

πŸ‡ΊπŸ‡Έ

Lexington, Kentucky, United States

S308.3.007 Site # 219

πŸ‡ΊπŸ‡Έ

Augusta, Georgia, United States

S308.3.007 Site # 212

πŸ‡ΊπŸ‡Έ

East Lansing, Michigan, United States

S308.3.007 Site # 100

πŸ‡¦πŸ‡·

Buenos Aires, Argentina

S308.3.007 Site # 101

πŸ‡¦πŸ‡·

Buenos Aires, Argentina

S308.3.007 Site # 107

πŸ‡¦πŸ‡·

Buenos Aires, Argentina

S308.3.007 Site # 103

πŸ‡¦πŸ‡·

Buenos Aires, Argentina

S308.3.007 Site # 105

πŸ‡¦πŸ‡·

CΓ³rdoba, Argentina

S308.3.007 Site # 108

πŸ‡¦πŸ‡·

Santa Fe, Argentina

S308.3.007 Site # 112

πŸ‡§πŸ‡·

Campinas, Brazil

S308.3.007 Site # 113

πŸ‡§πŸ‡·

Belo Horizonte, Brazil

S308.3.007 Site # 116

πŸ‡§πŸ‡·

MarΓ­lia, Brazil

S308.3.007 Site # 121

πŸ‡§πŸ‡¬

Sofia, Bulgaria

S308.3.007 Site # 133

πŸ‡¨πŸ‡¦

Halifax, Canada

S308.3.007 Site # 130

πŸ‡¨πŸ‡¦

Montreal, Canada

S308.3.007 Site # 138

πŸ‡¨πŸ‡¦

Peterborough, Canada

S308.3.007 Site # 135

πŸ‡¨πŸ‡¦

Sainte-Anne, Canada

S308.3.007 Site # 131

πŸ‡¨πŸ‡¦

Windsor, Canada

S308.3.007 Site # 139

πŸ‡¨πŸ‡¦

Toronto, Canada

S308.3.007 Site # 140

πŸ‡¨πŸ‡±

Santiago de Chile, Chile

S308.3.007 Site # 154

πŸ‡¨πŸ‡΄

Bogota, Colombia

S308.3.007 Site # 171

πŸ‡±πŸ‡Ή

Vilnius, Lithuania

S308.3.007 Site # 184

πŸ‡΅πŸ‡ͺ

Bellavista Callao, Peru

S308.3.007 Site # 170

πŸ‡±πŸ‡Ή

Vilnius, Lithuania

S308.3.007 Site # 181

πŸ‡΅πŸ‡ͺ

Lima, Peru

S308.3.007 Site # 180

πŸ‡΅πŸ‡ͺ

Lima, Peru

S308.3.007 Site # 193

πŸ‡·πŸ‡Ί

Kazan, Russian Federation

S308.3.007 Site # 183

πŸ‡΅πŸ‡ͺ

Lima, Peru

S308.3.007 Site # 191

πŸ‡·πŸ‡Ί

Saint-Petersburg, Russian Federation

S308.3.007 Site # 192

πŸ‡·πŸ‡Ί

Saint-Petersburg, Russian Federation

S308.3.007 Site # 198

πŸ‡·πŸ‡Ί

Saint-Petersburg, Russian Federation

S308.3.007 Site # 102

πŸ‡¦πŸ‡·

Buenos Aires, Argentina

Β© Copyright 2025. All Rights Reserved by MedPath